Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 681-690 of 9365

Page
per page
  1. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: IGF-IR/IR/ALK inhibitor, ATP-competitive
      ≥26.65 mg/mL
  2. GSK461364
    A8441 GSK461364
     3 Citation
    Target: PLK
    Summary: Plk1 inhibitor
  3. Guaifenesin
    A8442 Guaifenesin
    Summary: Expectorant agent
      ≥12.35 mg/mL
  4. GW3965 HCl
    A8444 GW3965 HCl
    Summary: LXR agonist, selective and orally active
      ≥30.55 mg/mL
  5. Ibuprofen
    A8446 Ibuprofen
    Target: COX
    Summary: inhibitor of cyclooxygenase 1 and cyclooxygenase 2
      insoluble in H2O; ≥10.31 mg/mL
  6. Imidapril HCl
    A8447 Imidapril HCl
    Target: ACE
    Summary: RAAS inhibitor
      insoluble in H2O; ≥16.5 mg/mL
  7. INCB28060
    A8448 INCB28060
     2 Citation
    Target: c-MET
    Summary: C-Met inhibitor,ATP-competitive and novel
      insoluble in EtOH; insoluble in H2O; ≥5.15 mg/mL
  8. Indomethacin
    A8449 Indomethacin
    Target: COX
    Summary: Cox inhibitor
  9. Isradipine (Dynacirc)
    A8453 Isradipine (Dynacirc)
    Summary: Calcium channel blocker
      ≥12.55 mg/mL
  10. Istradefylline (KW-6002)
    A8454 Istradefylline (KW-6002)
    Target: Adenosine A2A Receptors
    Summary: Selective A2A receptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥8.78 mg/mL

Items 681-690 of 9365

Page
per page